These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6262875)

  • 41. A comparison of hepatocellular carcinoma associated with HBV or HCV infection.
    Tanabe G; Nuruki K; Baba Y; Imamura Y; Miyazono N; Ueno K; Arima T; Nakajyou M; Aikou T
    Hepatogastroenterology; 1999; 46(28):2442-6. PubMed ID: 10522016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hepatoma-Australia antigen association. A case studied by electron microscopy and immunofluorescence].
    Bodin F; Scotto J; Homberg JC; Lichtenstein H; Roudier M; Huguet C
    Nouv Presse Med; 1974 Nov 9-23; 3(38-40):2487-9. PubMed ID: 4374684
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hepatitis-associated antigen and antibody in patients with hepatocellular carcinoma].
    Hirano Y
    Rinsho Byori; 1982 Jul; 30(7):758-63. PubMed ID: 6294381
    [No Abstract]   [Full Text] [Related]  

  • 45. Fibrolamellar carcinoma of the liver in a Japanese hepatitis B virus carrier.
    Morise Z; Sugioka A; Mizoguchi Y; Fujita J; Hoshimoto S; Kato T; Hasumi A
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1136-8. PubMed ID: 15955233
    [No Abstract]   [Full Text] [Related]  

  • 46. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
    [No Abstract]   [Full Text] [Related]  

  • 47. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatocellular carcinoma and hepatitis B virus markers in Europe.
    Vargas V; Pedreira JD; Vilaseca J; Ruiz J; Esteban R; Hernandez JM; Guardia J; Bacardi R
    Lancet; 1979 Mar; 1(8118):721-2. PubMed ID: 85956
    [No Abstract]   [Full Text] [Related]  

  • 50. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma, positive Australia (hepatitis-associated) antigen and sarcoidosis.
    Myerson RM; Soroush A; Skerrett PV
    Am J Dig Dis; 1971 Sep; 16(9):857-62. PubMed ID: 4329070
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
    Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
    Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serum hepatitis B antigen-antibody system in patients with hepatocellular carcinoma].
    Wu A; Cheng G
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):441-3. PubMed ID: 8697998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of an association between past infection with hepatitis A virus and primary hepatocellular carcinoma.
    Tabor E; Trichopoulos D; Manousos O; Zavitsanos X; Drucker JA; Gerety RJ
    Int J Epidemiol; 1980 Sep; 9(3):221-3. PubMed ID: 6254892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
    Ringe B; Böker K; Schlitt HJ; Sproviero J; Hundrieser J; Tillmann HL; Chavan A; Flemming P; Galanski M; Pichlmayr R
    Clin Transplant; 1995 Jun; 9(3 Pt 1):190-6. PubMed ID: 7549059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B infection and primary liver cancer.
    Maupas P; Melnick JL
    Prog Med Virol; 1981; 27():1-5. PubMed ID: 6262862
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis-associated antigen and hepatocellular carcinoma.
    Terés J; Guardia J; Bruguera M; Rodes J
    Lancet; 1971 Jul; 2(7717):215. PubMed ID: 4104876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.